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The extracellular matrix is composed of a large
number of different modular proteins. Matrilin-2 is a
newly described member of the protein superfamily
with von Willebrand factor A-like modules. To
examine the expression of matrilin-2 in human skin,
the distribution of protein and mRNA was studied by
immunohistochemistry and in situ hybridization. In
addition, immunoblotting and real-time reverse tran-
scription polymerase chain reaction were used to
investigate the expression of matrilin-2 in keratino-
cyte and ®broblast cultures. In vivo, keratinocytes and
®broblasts were both found to express matrilin-2
mRNA and deposit the protein at the basal side of the
dermal±epidermal basement membrane. Matrilin-2
molecules synthesized by the two cell types in vitro
appeared to be processed differently by cell-associated
proteases. Transcription of matrilin-2 mRNA in
keratinocytes was enhanced by a diffusible factor pro-
duced by ®broblasts, suggesting a regulatory mechan-
ism for the production of extracellular matrix at the
dermal±epidermal junction. These ®ndings demon-
strate that matrilin-2 is expressed in normal skin by
keratinocytes and ®broblasts and may thus contribute
to cutaneous homeostasis. Key words: cutaneous/extra-
cellular matrix/laminin/matrilin/skin. J Invest Dermatol
119:38±43, 2002
T
he extracellular matrix (ECM) is composed of a large
number of different molecules, which determine the
histoarchitecture speci®c to every organ and provide
cells with crucial information on migration, adhesion,
and differentiation (Krieg and LeRoy, 1998).
Molecules of the ECM are produced by adjacent cells such as
®broblasts, osteocytes, and epithelial cells and can ful®ll both
structural and regulatory functions. The expression and assembly of
ECM molecules is often determined by complex regulatory
processes, including transcriptional and translational events as well
as post-translational modi®cations. Most ECM molecules share
homologous modules that consist of speci®c protein domains
derived from a common evolutionary origin.
The family of matrilins are typical modular proteins belonging to
a superfamily characterized by von Willebrand factor A-like
domains (Deak et al, 1999; Paulsson et al, 1999). To date, four
different matrilins have been identi®ed, but their biologic role is
still largely unknown. Matrilin-1 (Paulsson and HeinegaÊrd, 1979;
Kiss et al, 1989), formerly also named cartilage matrix protein, and
matrilin-3 (Wagener et al, 1997; Belluoccio et al, 1998; Klatt et al,
2000) are mainly expressed in cartilage, whereas matrilin-2 (Deak
et al, 1997; Piecha et al, 1999) and matrilin-4 (Wagener et al, 1998a,
b; Klatt et al, 2001) have been found in a number of different
tissues. Mice lacking matrilin-1 show no overt phenotype, but an
abnormal cartilage collagen ®brillogenesis and ®bril organization
has been described (Huang et al, 1999; AszoÂdi et al, 1999). In
humans, immunoreactivity against matrilin-1 has been shown to be
involved in relapsing polychondritis (Buckner et al, 2000).
Matrilin-2 consists of 956 amino acids and is composed of two
von Willebrand factor A-like domains, 10 epidermal growth factor-
like modules, one unique sequence, and a coiled-coil domain
(Deak et al, 1997). Via the coiled-coil domain, matrilin-2 assembles
into oligomers, and monomers, dimers, trimers, and tetramers of
the matrilin-2 subunit can be detected in tissue extracts and in the
medium of cultured cells (Piecha et al, 1999). A similarly complex
band pattern is seen with matrilin-4 and, in this case, it has recently
been shown that the protein becomes proteolytically processed
before or at secretion (Klatt et al, 2001). The cleavage of matrilin-4
occurs C-terminal from two glutamic acid residues found in the
hinge region between the second von Willebrand factor A domain
and the coiled-coil region and results in the release of an almost
complete subunit from the rest of the molecule. In the homologous
region of the matrilin-2 sequence, two pairs of glutamic acid
residues occur and, by analogy, it is likely that the complex band
pattern seen with extracellular matrilin-2 (Piecha et al, 1999) is due
to an extensive proteolytic processing at these sites. The gene
coding for matrilin-2 has recently been mapped to chromosome
position 8q22 (Muratoglu et al, 2000). Expression of matrilin-2 has
been demonstrated in the ECM of different murine tissues,
including kidney, heart, lung, and esophagus (Piecha et al, 1999).
Matrilin-2 has also been shown to be present in murine skin, with a
prominent expression throughout the papillary dermis and around
skin appendages such as vessels, nerves, muscles, and sweat glands.
The human matrilin-2 precursor displays 93% similarity to the
mouse protein and gene expression has been demonstrated in
several human cell lines of ®broblastic and epithelial origin
(Muratoglu et al, 2000).
In order to elucidate the expression of matrilin-2 in human skin,
its protein and mRNA distribution was studied by immuno-
histochemistry and in situ hybridizaton. We show that matrilin-2
protein is mainly expressed at the dermal side of the basement
membrane and around skin appendages. Keratinocytes and
®broblasts both express matrilin-2 mRNA and protein, but appear
to process the secreted protein differently. Fibroblasts were found
to enhance expression of matrilin-2 mRNA in keratinocytes.
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MATERIALS AND METHODS
Tissue Normal skin was obtained with written consent of the patients.
Donors included an infant of a few weeks of age and adults between the
age of 40 and 60 y. Biopsies were either snap-frozen and stored at
±80°C until analysis or ®xed in 4% paraformaldehyde and embedded in
paraf®n.
Cell culture Primary human ®broblasts were established by outgrowth
from biopsies of normal skin as previously described (Krieg et al, 1980).
Fibroblasts were maintained in Dulbecco's modi®ed Eagle's medium
(DMEM) supplemented with 10% fetal bovine serum, 50 mg per ml
sodium ascorbate, 2 mM glutamine, and antibiotics. Primary human
keratinocytes were isolated as previously described (Watt, 1998) and
grown on feeder layers of 3T3 cells in FAD medium supplemented with
0.5 mg per ml insulin, 0.5 mg per ml hydrocortisone, 0.1 nM cholera
enterotoxin, and 10 ng per ml epidermal growth factor. For some
experiments, ®broblasts and keratinocytes were also cultured together for
48 h in a transwell system, where the two cell types were separated by a
porous membrane allowing the passage of supernatants but no direct
contact between the two cell types.
Immunohistochemistry Indirect immunoperoxidase staining of 6 mm-
thin cryosections was performed as previously described (Hauser and
Paulsson, 1994) using polyclonal af®nity-puri®ed antisera against matrilin-
2 (Piecha et al, 1999) or laminin-1, a swine antirabbit horseradish
peroxidase-conjugated IgG (Dako), and 3-amino-9-ethyl-carbazole
(Sigma) as reagents. To further investigate deposition of matrilin-2 at the
dermal±epidermal junction, indirect immunohistochemistry was also
performed on salt-split skin treated with 1 M NaCl at 4°C for 72 h as
previously described (Gammon et al, 1984; Zillikens et al, 1996).
Preparation of RNA probes Total RNA of human skin was isolated
using the RNeasy Mini Kit (Qiagen). Using 1 mg of cutaneous RNA as
template, reverse transcription was carried out using SuperscriptÔ II
RNase H± Reverse Transcriptase (Life Technologies). Polymerase chain
reaction (PCR) was performed using the following primers: for matrilin-
2, 5¢-AATGGAAAAGATGCTCGCAGG-3¢ (mat2h1) and sense 5¢-
TGATGCAGAAGTGGGCACAG-3¢ (mat2h2); for keratin 14, 5¢-ATG-
GCAGAGAAGAACCGCAAG-3¢ (kera1) and sense 5¢-GATCTT-
CCAGTGGGATCTGTG-3¢ (kera4); and AmpliTaq DNA Polymerase
(Perkin Elmer). The resulting 763 bp PCR product coding for matrilin-
2 as well as the 603 bp product coding for keratin 14 were cloned in the
pCRII Vector (Invitrogen). In vitro transcription of nonradioactive
antisense and sense RNAs was performed using the Digoxigenin
Labeling Kit (Roche Molecular Biochemicals). Nonradioactive antisense
and sense RNA probes transcribed from a 206 bp cDNA styI-KpnI
fragment coding for the 5¢ untranslated region of the a1(I) collagen were
kindly provided by Dr. N. Miosge (Department of Anatomy, University
of Goettingen, Germany) (Miosge et al, 1998).
In situ hybridization Four-micron-thin paraf®n-embedded sections
were dewaxed in xylene, rehydrated, and washed in phosphate-buffered
saline (PBS). After digesting with 10 mg per ml proteinase K, sections
were post®xed and acetylated with 0.25% acetic anhydride. Sections
were then hybridized overnight at 46°C with digoxigenin-labeled
riboprobes. As controls, serial sections were treated with a sense RNA
probe instead of the antisense probe. After hybridization, sections were
washed in 50% formamide, 2 3 sodium citrate/chloride buffer (SSC)
(0.3 M NaCl containing 0.03 M sodium citrate) at 42°C (matrilin-2 and
collagen type I) or 46°C (keratin 14) for 30 min, digested with RNase
A, and washed once with 2 3 SSC and twice with 0.2 3 SSC at 42°C
(matrilin-2 and collagen type I) or 46°C (keratin 14) for 20 min each.
Color detection of the digoxigenin-labeled sections was carried out as
recommended by the manufacturer (Roche Molecular Biochemicals)
with the additional use of polyvinyl alcohol in the detection buffer (De
Block and Debrouwer, 1993).
Northern hybridization In order to investigate epidermal and dermal
RNA separately, epidermis and dermis were separated by incubation
with 0.5 mg per ml thermolysin in 10 mM HEPES buffer containing
150 mM NaCl, 6 mM KCl, 1 mM CaCl2, and 1 mM MgCl2, pH 7.4,
overnight at 4°C. Total RNA and mRNA of epidermis and dermis were
prepared from guanidinium thiocyanate extracts using the isolation
RNeasy Kit and Oligotex mRNA Kit (Qiagen). For RNA blot analysis,
10 mg total RNA or 2 mg mRNA were electrophoresed, blotted to
Hybond N ®lters (Perkin Elmer), and hybridized with probes speci®c for
matrilin-2, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), or
collagen type I.
Immunoblot analysis Cells were washed in PBS and cultured in
serum-free DMEM, and supernatants were harvested after 48 h. In the
case of keratinocytes, feeder cells were ®rst removed by trypsin/
ethylenediamine tetraacetic acid and cells were then cultured with or
without ®broblasts in serum-free medium for 48 h. Supernatants were
analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) without prior reduction as previously described (Piecha
Figure 1. Cutaneous expression of matrilin-2 protein. Immuno-
histochemical staining of cryostat sections of human skin was performed
using an af®nity-puri®ed antiserum against matrilin-2. (A) Matrilin-2 is
mainly expressed at the basement membrane (bm) and around skin
appendages such as vessels (v) and hair follicles (f). Sections of salt-split
skin were also stained with antisera against matrilin-2 (B) or laminin-1
(C). The expression of matrilin-2 appears to be restricted to the lower,
dermal part of the basement membrane, whereas laminin-1 is expressed
at the dermal and the epidermal part of the membrane. e, epidermis; d,
dermis. Scale bar: 0.07 mm.
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et al, 1999). Brie¯y, proteins were electrophoresed on gradient gels
containing 4%±15% polyacrylamide, transferred to nitrocellulose ®lters,
and visualized using af®nity-puri®ed antiserum against matrilin-2, swine
antirabbit horseradish peroxidase-conjugated IgG (DAKO), and the ECL
chemiluminescence reagent (Amersham Pharmacia Biotech).
Real-time quantitative reverse transcription PCR (RT-PCR)
Fibroblasts and keratinocytes were cultured alone or in a transwell
coculture system, where the two cell types were separated by a
membrane, for 48 h. Total RNA was then isolated separately from each
cell type using the RNeasy Kit (Qiagen). One microgram of total RNA
was reversely transcribed with MuLV reverse transcriptase (Life
Technologies) using random hexamers. Pairs of primers for ampli®cation
of matrilin-2 and ribosomal protein s26 were designed using the Primer
Express Software (Applied Biosystems). In all experiments, primer
concentrations were ®rst optimized in order to avoid unspeci®c binding
of primers, and after running the PCR a dissociation curve analysis was
performed to verify the speci®city of the ampli®cation products. Primer
sequences used were as follows: 5¢-GACGGACGGGCTCAGGAT-3¢
(373mtr2) and 5¢-GATACCATTGGCCTTGGCTTTA-3¢ (432mtr2)
for matrilin-2, and sense 5¢-GCAGCAGTCAGGGACATTTCTG-3¢
and reverse 5¢-TTCACATACAGCTTGGGAAGCA-3¢ for ribosomal
protein s26.
Real-time quantitative PCR was performed using the GeneAmp 5700
system (Applied Biosystems) with the double-stranded DNA-binding dye
SYBR Green I and the AmpliTAQ gold polymerase (Applied
Biosystems). Quanti®cation of the samples was performed by measure-
ment of the threshold cycle using a standard curve that determines the
starting copy numbers of nucleic acid targets. To normalize the samples
for differences in the amounts of total RNA added to each cDNA
transcription, s26 ribosomal protein was used as endogenous control. To
avoid contamination, all assays were performed using the universal
thermal cycling parameters (Applied Biosystems) with AmpErase UNG.
All experiments were performed in duplicate.
RESULTS
Cutaneous expression of matrilin-2 protein To study the
expression of matrilin-2 in normal human skin, indirect
immunohistochemistry was performed (Fig 1A). Deposition of
matrilin-2 protein was restricted to a narrow zone close to the
basement membrane at the dermal±epidermal junction and to areas
around vessels and appendages. Similar results were obtained from
individuals of different age. Sections of salt-split skin demonstrated
that the deposition of matrilin-2 is restricted to the lower, dermal
part of the basement membrane zone (Fig 1B). In contrast,
laminin-1, which is known to be an integral protein of the
basement membrane, was found at the lower as well as the upper
part of the basement membrane (Fig 1C).
Cutaneous expression of matrilin-2 mRNA In order to
investigate the cellular source of matrilin-2, in situ hybridization of
human skin was performed (Fig 2). In contrast to the protein
distribution, matrilin-2 mRNA was found to be expressed in both
the epidermis and dermis (Fig 2A). Keratinocytes, ®broblasts, and
endothelial cells all showed expression of matrilin-2 mRNA. The
speci®city of the method used was demonstrated by the fact that an
antisense riboprobe for keratin 14 hybridized speci®cally to basal
keratinocytes (Fig 2C) and a probe for the a1 chain of collagen
type I to dermal ®broblasts (Fig 2E).
To quantify the expression of matrilin-2 mRNA in different
cutaneous layers, northern blot analysis was additionally performed
using separated dermal and epidermal tissue after treatment with
thermolysin (Fig 3). Total RNA was isolated from dermis and
epidermis and hybridized with a probe speci®c for matrilin-2
(Fig 3A). Matrilin-2 mRNA showed nearly equal expression in
Figure 2. In situ hybridization of matrilin-2
cRNA to human skin. Nonradioactive antisense
(A) and sense (B) riboprobes speci®c for matrilin-
2 mRNA were hybridized to paraf®n-embedded
sections of human skin. Matrilin-2 mRNA is
found to be expressed in the epidermis and
dermis. The speci®city of the nonradioactive
method was demonstrated using antisense (C) and
sense (D) riboprobes for keratin 14 and antisense
(E) and sense (F) riboprobes for the a1 chain of
collagen type I that hybridized speci®cally to basal
keratinocytes or dermal ®broblasts, respectively.
Scale bar: 0.1 mm.
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dermis and epidermis. Equal loading of RNA was con®rmed by
GAPDH hybridization (Fig 3B). To exclude contamination from
other cutaneous layers, hybridization of dermis-speci®c collagen
type I mRNA was also performed (Fig 3C).
Expression of matrilin-2 protein in primary ®broblasts and
keratinocytes Serum-free supernatants from primary keratino-
cytes and ®broblasts as well as from cocultures of ®broblasts with
keratinocytes were analyzed by SDS-PAGE under nonreducing
conditions followed by immunoblotting with af®nity-puri®ed
antiserum against matrilin-2 (Fig 4). Both cell types secreted
matrilin-2 protein, which was detected as a heterogeneous set of
speci®cally stained bands between 60 and 500 kDa in agreement
with earlier results demonstrating expression of matrilin-2 in a
variety of cell cultures and tissue extracts (Piecha et al, 1999). This
heterogeneity is probably due to a propensity of matrilins for
proteolytic processing at the time they are secreted (Piecha et al,
1999; Klatt et al, 2001). Marked differences between ®broblasts and
keratinocytes were noted regarding the mobility of the matrilin-2
bands and the relative amounts of expression. Most prominently, a
66 kDa band seen in media from ®broblasts as well as cocultures
was absent in keratinocyte-derived supernatant. The band patterns
of the cocultures were qualitatively similar to the combined
migration patterns of matrilin-2 secreted from keratinocytes and
®broblasts.
Fibroblasts modulate matrilin-2 mRNA expression in
human keratinocytes Steady-state levels of matrilin-2 mRNA
expressed by ®broblasts, keratinocytes, and cocultures of both cell
types were studied by real-time quantitative RT-PCR (Fig 5).
Keratinocytes expressed higher amounts of matrilin-2 mRNA
compared to dermal ®broblasts. Whereas coculture with ®broblasts
induced an enhanced expression of matrilin-2 in keratinocytes,
®broblasts failed to show an altered expression after contact with
keratinocytes.
Figure 3. Northern hybridization of matrilin-2 mRNA in
epidermis and dermis. Using thermolysin, the epidermis (e) and
dermis (d) of human skin were separated and northern hybridization of
mRNA was performed to investigate the distribution of matrilin-2
mRNA in different cutaneous layers. (B) Equal loading by hybridization
of GAPDH. (C) Successful separation of the epidermis from dermis by
exclusive hybridization of dermis-speci®c collagen type I mRNA to
dermal tissue. Matrilin-2 mRNA is nearly equally expressed in dermis
and epidermis.
Figure 4. Expression of matrilin-2 protein in primary ®broblasts
and keratinocytes. Supernatants from cultures of primary keratinocytes,
dermal ®broblasts, or cocultures of keratinocytes with ®broblasts were
analyzed by SDS-PAGE without prior reduction. Proteins were
transferred to nitrocellulose ®lters and matrilin-2 was visualized by use of
the af®nity-puri®ed antiserum against matrilin-2. In both cell types, a
heterogeneous set of speci®cally stained bands is seen migrating between
60 and 500 kDa. Marked differences in the mobility of the matrilin-2
bands between ®broblasts and keratinocytes are found. The migration
positions of molecular mass standards and unreduced ®bronectin (Fn) are
indicated.
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DISCUSSION
Most murine cells producing matrilin-2 are of mesodermal origin
(Piecha et al, 1999). Epithelial cells have also been shown to express
matrilin-2 mRNA, but protein deposition was only observed in
adjacent subepithelial tissues. In murine skin, matrilin-2 has been
demonstrated to be prominently expressed throughout the upper
dermis and around vessels, nerves, muscles, and sweat glands
(Piecha et al, 1999).
In this study, the expression of matrilin-2 in human skin clearly
differed from the expression in murine skin. In humans, matrilin-2
protein was con®ned to a narrow zone close to the basement
membrane at the dermal±epidermal junction and to areas around
blood vessels. Staining of salt-split skin and comparison with the
distribution of the ubiquitous basement membrane protein laminin
demonstrated that matrilin-2 is only deposited at the lower part of
the basement membrane or the upper part of the dermis adjacent to
the basement membrane. In situ hybridization and northern blot
analysis also revealed that matrilin-2 mRNA in humans was found
in both dermis and epidermis. Although matrilin-2 protein was not
abundant in resting epidermis, keratinocytes in culture were also
clearly capable of expressing matrilin-2. It may therefore be that
translation of matrilin-2 mRNA is determined by extracellular
in¯uences. Alternatively, matrilin-2 may be produced by epidermal
keratinocytes, but would then rapidly be transported to subepi-
thelial tissues. A similar mechanism of protein processing has been
suggested for laminin (Smola et al, 1998) and collagen type VII
(KoÈnig and Bruckner-Tuderman, 1994), although it is not known
how these proteins are transported across the basement membrane
and how they are then incorporated into the mesenchymal stroma.
The presence of speci®c binding ligands or interacting partners may
be associated with the restricted deposition of matrilin-2 protein in
the basement membrane zone.
In vitro studies also showed that primary dermal ®broblasts and
keratinocytes are able to secrete matrilin-2 protein. As has been
described, the secreted matrilin-2 displayed a large structural
heterogeneity (Piecha et al, 1999), presumably corresponding to
post-translational modi®cations speci®c for each cellular origin. In
analogy with the better studied matrilin-4 (Klatt et al, 2001), it is
likely that this heterogeneity is related to proteolytic processing,
with ®broblasts yielding smaller fragments than keratinocytes.
When the pooled media from cocultures were analyzed, the band
pattern observed largely corresponded to the sum of the patterns
obtained with the two cell types in separate cultures and the larger
components produced by keratinocytes were not further degraded
by ®broblast proteases. It can thus be concluded that the proteases
contributing to the processing must be cell-associated and are not
able to act on matrilin-2 secreted by another cell type. Further, the
pronounced cleavage of matrilin-2 by ®broblasts (Fig 4) may
hamper the matrix deposition of protein secreted by these cells.
The transcription of matrilin-2 mRNA in keratinocytes is
enhanced by coculture with ®broblasts, whereas the same process in
®broblasts is not affected by the presence of keratinocytes.
Accordingly, ®broblasts must release a diffusible factor regulating
matrilin-2 gene expression. It is possible that such interplay
between ®broblasts and keratinocytes is of importance in regulating
ECM production during wound healing.
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